Concepedia
Statistics
Publications
63
Citations
4.8K
H-Index
33
Active since
2013
Affiliations
University of Arizona(Current)
University of South Florida
Rutgers, The State University of New Jersey
The University of Texas at San Antonio Health Science Center
National and Kapodistrian University of Athens
Yanmei Hu is an author at University of Arizona specializing in virology, antiviral therapy, and antiviral pharmacology.
Publications per year
2013–2024
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma, M. Sacco, Brett L. Hurst et al. · Cell Research · 2020 · 885 citations · Full text
Pharmacy, Infectious Diseases, Medicinal Chemistry +17
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 399 citations · Full text
Life Sciences, Biochemistry, Medicinal Chemistry +14
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
Yanmei Hu, Eric M. Lewandowski, Haozhou Tan et al. · ACS Central Science · 2023 · 306 citations · Full text
Life Sciences, Infectious Diseases, Molecular Biology +17
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma, Yanmei Hu, Julia A. Townsend et al. · ACS Pharmacology & Translational Science · 2020 · 272 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
Chunlong Ma, M. Sacco, Zilei Xia et al. · ACS Central Science · 2021 · 198 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Biology +14
1–5 of 63